Lucy Scientific Discovery, Inc.

Lucy Scientific Discovery, Inc. (LSDI) priced its initial public offering on Feb 10, 2023 at $4.00 per share, raising $7.5M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $65.1M. WestPark was lead-left underwriter. Troutman Pepper and Tingle Merrett advised the company and Nelson Mullins advised the underwriters.

Lucy Scientific Discovery, Inc. is an early-stage contract manufacturing company for psychotropics-based medicines. Through a subsidiary, it holds a Health Canada Controlled Drugs and Substances Dealer's Licence and aims to become a contract research, development and manufacturing organization for the sector.

Status

IPO

Ticker

LSDI

Exchange

Nasdaq Capital Market

Priced

Feb 10, 2023

IPO price

$4.00

Raised

$7.5M

Market cap at IPO price

$65.1M

First filed

Jan 21, 2022

Underwriters

WestPark

Company counsel

Troutman Pepper and Tingle Merrett

Underwriters' counsel

Nelson Mullins

Sector

Biotech & pharma

Country / state

British Columbia, Canada

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.